Abstract
Introduction: Many clinical and observational studies have demonstrated effectiveness of omalizumab (OMA) in the treatment of severe asthma, but the optimal duration of the therapy remains unknown. Aim: The article presents the authors’ clinical experience on OMA cessation in routine...

This publication has 15 references indexed in Scilit: